Statins and Risk of Myocardial Infarction in Real Life in France

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00679575
First received: May 15, 2008
Last updated: December 6, 2010
Last verified: December 2010

May 15, 2008
December 6, 2010
March 2007
November 2010   (final data collection date for primary outcome measure)
Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France [ Time Frame: in 2011 ]
Same as current
Complete list of historical versions of study NCT00679575 on ClinicalTrials.gov Archive Site
  • Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities [ Time Frame: in 2011 ]
  • Assess the populational impact of statins usage on the risk of having a first myocardial infarction [ Time Frame: in 2011 ]
  • Assess the risk of having a first myocardial infarction according to high and low dosages of statins [ Time Frame: in 2011 ]
Same as current
Not Provided
Not Provided
 
Statins and Risk of Myocardial Infarction in Real Life in France
Statins and Risk of Myocardial Infarction in Real Life in France

The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Cases : Patients recruited by a cardiologist in hospital / Referents : Patients recruited by a GP, community sample

Myocardial Infarction
Not Provided
  • 1
    Cases : Patients with a first myocardial infarction
  • 2
    Referents : Patients recruited by a GP during a routine consultation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
13171
November 2010
November 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients can speak French or English
  • Patients can be interviewed by telephone
  • Place of usual residence in the area of recruitment

Exclusion Criteria:

  • Patients refusing to participate in the study
  • Patients who cannot be reached by telephone
  • Previous history of myocardial infarction
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00679575
NIS-CFR-CRE-2007/1
Yes
Russel Esterline, AstraZeneca
AstraZeneca
Not Provided
Study Chair: Lucien Abenhaim LA-SER29, rue du Faubourg Saint-Jacques75014 Paris
AstraZeneca
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP